| Date Filed | Type | Description |
| 04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/08/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/07/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/31/2022 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Bought 141,000 shares
@ $0.3525, valued at
$49.7k
|
|
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 300,000 shares
@ $0
Granted 300,000 options to buy
@ $0.49, valued at
$147k
|
|
| 02/23/2022 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 450,000 shares
@ $0
Granted 450,000 options to buy
@ $0.49, valued at
$220.5k
|
|
| 02/23/2022 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 750,000 shares
@ $0
Granted 750,000 options to buy
@ $0.49, valued at
$367.5k
|
|
| 01/04/2022 |
4
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Disposed/sold 120,000 shares
@ $0 |
|
| 01/04/2022 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Disposed/sold 120,000 shares
@ $0 |
|
| 01/04/2022 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Disposed/sold 300,000 shares
@ $0 |
|
| 12/20/2021 |
4
| Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Bought 25,000 shares
@ $0.389, valued at
$9.7k
|
|
| 12/20/2021 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Bought 40,594 shares
@ $0.37, valued at
$15k
|
|
| 12/20/2021 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Bought 135,000 shares
@ $0.375, valued at
$50.6k
|
|
| 07/09/2021 |
4
| Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 19,998 shares
@ $0.975, valued at
$19.5k
|
|
| 06/21/2021 |
4
| Kamdar Kim P. (Director) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Bought 10,000 shares
@ $1.165, valued at
$11.7k
|
|
| 06/14/2021 |
4
| Rarick Lisa Dale (Director) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Bought 5,000 shares
@ $1.198, valued at
$6k
|
|
| 06/14/2021 |
4
| O'Brien Anthony Stephen (Director) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Bought 8,140 shares
@ $1.31, valued at
$10.7k
|
|
| 06/11/2021 |
4
| Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Bought 18,180 shares
@ $1.14, valued at
$20.7k
|
|
| 06/10/2021 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Bought 24,500 shares
@ $1.03, valued at
$25.2k
|
|
| 06/10/2021 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Bought 50,000 shares
@ $1.03, valued at
$51.5k
|
|
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 31,480 shares
@ $0.86, valued at
$27.1k
|
|
| 05/21/2021 |
4
| Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 42,061 shares
@ $0.86, valued at
$36.2k
|
|
| 05/21/2021 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 42,280 shares
@ $0.86, valued at
$36.4k
|
|
| 05/21/2021 |
4
| PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 105,300 shares
@ $0.86, valued at
$90.6k
|
|
| 05/13/2021 |
4
| Greer Gillian (Director) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 90,000 options to buy
@ $1.25, valued at
$112.5k
|
|
| 05/13/2021 |
4
| Rutherford Colin (Director) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 90,000 options to buy
@ $1.25, valued at
$112.5k
|
|
|